Delayed publication of clinical trials in gynecologic oncology

• Published in: Gynecologic oncology 2024-04, Vol.183, p.74-77
• Main Authors: Salinaro, Julia R., Rossi, Emma C., Penvose, Katherine N., Zhang, Yingao, Darling, Alice J.
• Format: Article
• Language: English
• Subjects: Clinical trials
• ISSN: 0090-8258; 1095-6859; 1095-6859
• DOI: 10.1016/j.ygyno.2024.03.018

Delays in clinical trial publication can hinder timely implementation of evidence-based practices. We sought to determine publication rates and time to publication for clinical trials addressing gynecologic malignancies. All clinical trials addressing gynecologic cancers in the ClinicalTrials.gov registry with a primary completion date between 1/1/2018 and 1/1/2020 were identified. The primary outcome was publication rate. All included studies had been completed for at least 3 years. Secondary outcomes were time to publication and associations between publication rate and sponsor, cancer type, and the number and location of primary study sites. Of the 290 trials included, 161 (55.5%) had a peer-reviewed publication for the primary outcome within at least 3 years after completion. Of these, 123 had positive results (76.4%) and 38 were negative (23.6%). The average duration from primary completion to manuscript publication was 23.6 months (SD 13.9; median 21.4, IQR 15.1–32.4). Only 73 had results posted on the ClinicalTrials.gov registry (25.2%). Studies with positive findings had a significantly faster time to publication than those with negative results (22.0 mo vs 29.0 mo, p = 0.009). There was no significant difference between publication rate and funding source, cancer type, or location and number of primary sites. Timely publication of clinical trials addressing gynecologic cancers remains an issue. Studies with positive findings were published faster than those with negative results, but the average publication time was still almost 2 years from trial completion. Further efforts should be made to identify and address barriers to clinical trial publication. •Clinical trials are the foundation of evidence-based practices in gynecologic oncology.•Only half of clinical trials in gynecologic oncology are published within 3 years of completion.•The average time to publication is almost 2 years.•Studies with positive results are published faster than those with negative findings.•Efforts should be made to address barriers to timely clinical trial publication.